Literature DB >> 22715474

About fACE: perioperative use of angiotensin-converting enzyme inhibitors.

Viachaslau Barodka, Daniel Nyhan, Dan Berkowitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22715474      PMCID： PMC4360133          DOI： 10.1161/CIRCULATIONAHA.112.117671

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  18 in total

Review 1.  Calcium channel blockers: an update.

Authors:  Mark J Eisenberg; Anya Brox; Alain N Bestawros
Journal:  Am J Med       Date:  2004-01-01       Impact factor: 4.965

2.  Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality.

Authors:  Benjamin Drenger; Manuel L Fontes; Yinghui Miao; Joseph P Mathew; Yaacov Gozal; Solomon Aronson; Cynthia Dietzel; Dennis T Mangano
Journal:  Circulation       Date:  2012-06-19       Impact factor: 29.690

3.  Glucose control in the ICU--how tight is too tight?

Authors:  Silvio E Inzucchi; Mark D Siegel
Journal:  N Engl J Med       Date:  2009-03-24       Impact factor: 91.245

4.  Angiotensin-converting enzyme inhibitor therapy at the time of coronary artery bypass surgery: when a friend turns mean-spirited.

Authors:  David S Bach
Journal:  J Am Coll Cardiol       Date:  2009-11-03       Impact factor: 24.094

Review 5.  Should more patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome.

Authors:  Neal Stuart Gerstein; Peter Mark Schulman; Wendy Hawks Gerstein; Timothy Randal Petersen; Isaac Tawil
Journal:  Ann Surg       Date:  2012-05       Impact factor: 12.969

Review 6.  Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.

Authors:  Roberto Ferrari; Gabriele Guardigli; Claudio Ceconi
Journal:  Cardiovasc Drugs Ther       Date:  2010-08       Impact factor: 3.727

7.  Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America.

Authors:  T Bruce Ferguson; Laura P Coombs; Eric D Peterson
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

8.  Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial.

Authors:  Ludhmila A Hajjar; Jean-Louis Vincent; Filomena R B G Galas; Rosana E Nakamura; Carolina M P Silva; Marilia H Santos; Julia Fukushima; Roberto Kalil Filho; Denise B Sierra; Neuza H Lopes; Thais Mauad; Aretusa C Roquim; Marcia R Sundin; Wanderson C Leão; Juliano P Almeida; Pablo M Pomerantzeff; Luis O Dallan; Fabio B Jatene; Noedir A G Stolf; Jose O C Auler
Journal:  JAMA       Date:  2010-10-13       Impact factor: 56.272

9.  Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting.

Authors:  Antonio Miceli; Radek Capoun; Carlo Fino; Pradeep Narayan; Alan J Bryan; Gianni D Angelini; Massimo Caputo
Journal:  J Am Coll Cardiol       Date:  2009-08-13       Impact factor: 24.094

10.  The risk of myocardial infarction associated with antihypertensive drug therapies.

Authors:  B M Psaty; S R Heckbert; T D Koepsell; D S Siscovick; T E Raghunathan; N S Weiss; F R Rosendaal; R N Lemaitre; N L Smith; P W Wahl
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.